ESG Strategy, Materiality and Risk Assessment for Pharma

ESG Strategy, Materiality and Risk Assessment for Pharma
Product Description

Positive Organizations builds the ESG strategy that sits underneath everything else, so your reporting, ratings and customer questionnaires draw on one coherent plan instead of ad hoc answers.


We begin with an ESG maturity assessment and a peer benchmark against comparable pharmaceutical manufacturers, CDMOs, API and packaging suppliers, followed by a structured gap analysis against the frameworks your customers and regulators actually apply: ESRS, GRI, EcoVadis and PSCI expectations.


From there we develop your ESG strategy with measurable KPIs, named owners and a phased action plan, complemented by ESG risk scoring and a TCFD-aligned climate risk assessment using IPCC scenarios. Our 360 ESG roadmap phases this support over several years.


We also build your ESG communication plan, so demonstrated progress reaches procurement, investors and auditors.

Read more Show less

Positive Organizations

  • Country/Region:
    Switzerland
  • On CPHI since:
    2026
  • Certificates:
    1
  • Employees:
    1 - 24
Company types
Consultancy
Primary activities
Other
Regulatory Affairs
View company profile
Categories
more categories Show less
Specifications
  • Details
    Standards and references: ESRS (revised standards adopted July 2026), GRI 1, 2 and 3 (2021), EcoVadis 21 criteria across 4 themes, TCFD and IFRS S2, IPCC scenario pathways, PSCI Principles.


    Scope: ESG maturity assessment and peer benchmarking; materiality and gap analysis; ESG strategy with KPIs, targets, owners and timelines; 360 ESG roadmap phased over multiple years; ESG risk scoring and mitigation planning; physical and transition climate risk modelling, scenario analysis and risk mapping; stakeholder analysis, ESG messaging and channel strategy.


    Deliverables: maturity and benchmark report, materiality matrix, prioritised gap list, multi-year roadmap, ESG risk register, climate risk map, communication plan.


    Application areas: pharma and biotech manufacturers, CDMOs and CMOs, API, excipient and packaging suppliers, distributors, laboratory and logistics providers.
  • Selling Points
    Green Product; International Approvals/Standards; Quality Service; - Swiss-based ESG specialists focused on the pharmaceutical value chain
    - One strategy that feeds ESRS, GRI, EcoVadis, CDP and customer questionnaires
    - Benchmarked against comparable pharma suppliers, not generic industry averages
    - Climate risk modelled on IPCC scenarios, TCFD-aligned
    - Phased 360 roadmap: multi-year support, not a single report
    - KPIs your board and your customers can both act on
  • Supplied from
    Switzerland
More specifications Fewer specifications
Sales Markets
Show more Show less

Positive Organizations

  • Country/Region:
    Switzerland
  • On CPHI since:
    2026
  • Certificates:
    1
  • Employees:
    1 - 24
Company types
Consultancy
Primary activities
Other
Regulatory Affairs
View company profile

More Products from Positive Organizations (10)

  • Carbon Neutrality to ISO 14068-1 and Credible Climate Claims

    Product Carbon Neutrality to ISO 14068-1 and Credible Climate Claims

    Positive Organizations supports pharmaceutical companies that want to make a carbon neutrality claim and have it stand up to scrutiny.


    The rules changed. From 27 September 2026, Directive (EU) 2024/825 on empowering consumers for the green transition prohibits product claims such as carbon neutr...
  • Circular Economy, Resource Efficiency and Reffnet Consultancy

    Product Circular Economy, Resource Efficiency and Reffnet Consultancy

    Positive Organizations helps pharmaceutical manufacturers and packaging suppliers cut material and resource losses and build a credible circularity position.


    We map resource and material flows across your processes, visualise them with Sankey diagrams, benchmark efficiency against comparable ope...
  • Corporate Carbon Footprint, Decarbonization and Energy Assessment

    Product Corporate Carbon Footprint, Decarbonization and Energy Assessment

    Positive Organizations calculates your corporate carbon footprint, a greenhouse gas inventory covering Scope 1, Scope 2 and material Scope 3 categories, and then turns it into a reduction plan.


    At least 55 percent of pharmaceutical emissions sit in Scope 3, and manufacturing accounts for the maj...
  • EcoVadis, CDP and S&P CSA Rating Support and Gap Analysis

    Product EcoVadis, CDP and S&P CSA Rating Support and Gap Analysis

    Positive Organizations is an EcoVadis Accredited Consulting Partner and Approved Training Partner, and improves the ratings your pharmaceutical customers use to screen suppliers.


    EcoVadis scores you from 0 to 100 across Environment, Labor and Human Rights, Ethics and Sustainable Procurement, jud...
  • ESG Governance, Policies, Training, DEI and Leadership Coaching

    Product ESG Governance, Policies, Training, DEI and Leadership Coaching

    Positive Organizations puts the governance layer in place that ESG ratings, auditors and customers all look for, and then makes it live in the organisation.


    We draft the ESG documentation suite: whistleblower policy and reporting channel, code of conduct, code of ethics, human rights, anti-corru...
  • ESG Supply Chain Due Diligence and Supplier Assessment

    Product ESG Supply Chain Due Diligence and Supplier Assessment

    Positive Organizations builds the supplier ESG due diligence system that pharmaceutical procurement now requires, and that upstream regulation increasingly assumes.


    Around 55 percent or more of pharmaceutical emissions and most human rights exposure sit with suppliers, and 69 percent of pharma l...
  • ISO Certifications and B Corp Certification Support

    Product ISO Certifications and B Corp Certification Support

    Positive Organizations takes pharmaceutical companies and suppliers through management system certification and B Corp certification, from gap analysis to certificate.


    We support ISO 14001 environmental management, ISO 50001 energy management, ISO 45001 occupational health and safety, ISO 20121 ...
  • Life-Cycle Assessment and Product Carbon Footprint for Pharma

    Product Life-Cycle Assessment and Product Carbon Footprint for Pharma

    Positive Organizations conducts product and process life-cycle assessments to ISO 14040 and ISO 14044, quantifying the environmental impact of an API, a formulation, a device or a packaging system from raw material to end of life.


    In pharmaceutical manufacturing the impact is concentrated upstre...
  • PPWR Readiness Assessment for Pharma Packaging

    Product PPWR Readiness Assessment for Pharma Packaging

    Regulation (EU) 2025/40 (PPWR) has applied across the EU-27 since 12 August 2026. For pharma the exposure is uneven: primary packaging of medicinal products is exempt from the recyclability and recycled-content targets — but that exemption has to be documented, and secondary, transport and e-commerce packa...
  • Sustainability Reporting: GRI, CSRD and ESRS, plus ESG Data Management

    Product Sustainability Reporting: GRI, CSRD and ESRS, plus ESG Data Management

    Positive Organizations produces GRI-aligned and CSRD-compliant sustainability reports for pharmaceutical companies and their suppliers.


    Following the Omnibus I Directive (EU) 2026/470, mandatory ESRS reporting now applies to undertakings with more than 1,000 employees and over EUR 450 million tu...